Table 1:
Characteristic | Group; % (no.) of patients* | |
---|---|---|
Prednisolone n = 93 |
Placebo n = 92 |
|
Age, yr, mean (SD) | 43.9 (13.6) | 42.4 (13.7) |
Sex, female | 67.7 (63/93) | 55.4 (51/92) |
Smoking history | ||
Never | 38.2 (34/89) | 41.6 (37/89) |
Former | 33.7 (30/89) | 39.3 (35/89) |
Current | 28.1 (25/89) | 19.1 (17/89) |
Medical history | ||
Recent history of rhinosinusitis† | 32.6 (30/92) | 32.2 (29/90) |
Asthma | 6.5 (6/92) | 8.9 (8/90) |
Seasonal allergic rhinitis | 19.6 (18/92) | 18.0 (16/89) |
Eczema | 6.5 (6/92) | 8.9 (8/90) |
Chronic obstructive pulmonary disease | 1.1 (1/92) | 1.1 (1/89) |
Duration of symptoms, d, median (IQR) | 12 (7–20) | 13.5 (7–21) |
Initial temperature, °C, median (IQR) | 36.7 (36.3–37.0) | 36.7 (36.3–37.0) |
Pus on inspection | 20.4 (19/93) | 20.9 (19/91) |
Postnasal drip on inspection | 19.3 (17/88) | 16.7 (15/90) |
Nasal congestion | 83.9 (78/93) | 84.8 (78/92) |
Facial pain or pressure | 95.7 (89/93) | 95.7 (88/92) |
Unilateral | 36.5 (27/74) | 39.5 (30/76) |
Bilateral | 63.5 (47/74) | 60.5 (46/76) |
Severity of facial pain, score,‡ mean (SD) | 3.0 (1.3) | 3.1 (1.4) |
Severity of problem according to physician | ||
Mild problem | 28.0 (26/93) | 30.3 (27/89) |
Moderate problem | 67.7 (63/93) | 68.5 (61/89) |
Severe problem | 4.3 (4/93) | 1.1 (1/89) |
Laboratory measurement | ||
Positive result of Phadiatop test (atopic status) | 35.4 (29/82) | 27.3 (21/77) |
Note: IQR = interquartile range, SD = standard deviation.
Unless stated otherwise.
Consultation with physician because of rhinosinusitis in the 3 years before the study.
Score assigned by patient (0 = no problem, 1 = very mild problem, 2 = mild problem, 3 = moderate problem, 4 = severe problem, 5 = problem as bad as it can be).